From October 31st to November 2nd, 2023, ICGEB orgnizes a conference about prostate and cervical cancer in Cape Town.
Nearly 10 million people died from cancer in 2020. The disease incidence is increasing for several reasons:
- an aging population – most of the people diagnosed with cancer are older than 60;
- dietary changes;
- tobacco and alcohol use;
- lack of physical activity;
- cancer-causing infections, such as human papillomavirus (HPV) and hepatitis are also important drivers of increased cancer incidence.
Prostate and Cervix
Globally, prostate cancer is the second most common cancer. Among African men, it is ranked 1st in both incidence and mortality. Growing knowledge of human genetics is changing the way physicians and researchers approach both the diagnosis and the treatment of cancer. Genomic information about prostate cancer is leading to better diagnoses and treatment strategies.
Cervical cancer is a preventable disease: its main cause is persistent infection with human papillomavirus (HPV), which is transmitted through sexual contact. Vaccines exist that protect against high-risk HPV types, and screening programmes can detect signs of disease. However, high incidence rates and high mortality rates for cervical cancer occur mainly in low- and middle-income countries.
Molecular aspects of cancer
Several key technologies have emerged in biomedical research. These types of analyses are now critical for performing effective research aimed at developing a better understanding of disease pathology, as well as for designing new approaches for clinical treatment. The Arturo Falaschi Conference “Advances in prostate and cervical cancer research” will focus on the basic and molecular aspects of prostate and cervical cancer diseases.
The aim is to give an overview of the current scenario of these diseases, how their research fields are progressing, how to obtain valuable information from them, and how to teach this information to others.
Several outstanding speakers and leading experts will talk during this conference:
- Vanessa Hayes, University of Sydney, Australia
- Carlo Catapano, Institute of Oncology Research, Switzerland
- Giuseppina Carbone, Institute of Oncology Research, Switzerland
- Karl Munger, Tufts University, USA
- John Doorbar, University of Cambridge, United Kingdom
- Lynette Denny, University of Cape Town, South Africa
- Allen Matubu, University of Zimbabwe, Zimbabwe
It will also be an excellent opportunity to meet with exceptional investigators from all over the world, creating an unparalleled opportunity for networking and collaboration.
You can also have a look at the conference page on the ICGEB website.
